Literature DB >> 6548793

Additive hypocalciuric effects of amiloride and hydrochlorothiazide in patients treated with calcitriol.

U Alon, L S Costanzo, J C Chan.   

Abstract

To compare the effects of hydrochlorothiazide (HCTZ) alone and in combination with amiloride on urinary calcium excretion we performed 14 acute studies on 7 patients with vitamin-D-induced calciuria. Each patient was studied first with HCTZ alone, and 1-32 weeks later with the same or lower dose of HCTZ combined with amiloride. Administration of HCTZ alone did not change UCaV during the 1st day of therapy, and caused a significant reduction from 44.4 +/- 28.8 to 26.0 +/- 14.4 mg/m2/24 h (p less than 0.02) on the 4th day. In contrast, combined diuretic regimen caused a significant reduction in UCaV from 36.0 +/- 16.7 to 23.6 +/- 14.4 mg/m2/24 h (p less than 0.02) on the 1st day and further reduction to 13.3 +/- 6.9 mg/m2/24 h (p less than 0.01) on the 4th day. UCaV on the 4th day was significantly lower with the HCTZ-amiloride combination (p less than 0.05). The combined therapy caused a greater reduction in FECa/FENa than HCTZ alone on the 1st day (p less than 0.02) and on the 4th day (p less than 0.01). HCTZ-induced hyperkaluria, hypokalemia and alkalosis were prevented by the addition of amiloride. In another patient, low-dose HCTZ-amiloride had a maximal dissociative effect on FECa/FENa and was more effective than HCTZ given alone in a double dose. 3 patients were treated with the low-dose HCTZ-amiloride regimen for a total of 23 months. UCaV was kept persistently low.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548793

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  7 in total

Review 1.  Pediatric urolithiasis: causative factors, diagnosis and medical management.

Authors:  Funda Baştuğ; Ruhan Düşünsel
Journal:  Nat Rev Urol       Date:  2012-02-07       Impact factor: 14.432

Review 2.  Corticosteroid-Induced osteoporosis: detection and management.

Authors:  J D Adachi; A Papaioannou
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

3.  Resolution of medullary nephrocalcinosis in children with metabolic bone disorders.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2005-06-23       Impact factor: 3.714

4.  Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.

Authors:  Paulette D Chandler; Jamil B Scott; Bettina F Drake; Kimmie Ng; John P Forman; Andrew T Chan; Gary G Bennett; Bruce W Hollis; Edward L Giovannucci; Karen M Emmons; Charles S Fuchs
Journal:  Am J Med       Date:  2014-03-20       Impact factor: 4.965

Review 5.  Current medical treatment in pediatric urolithiasis.

Authors:  Yiğit Akın; Murat Uçar; Selçuk Yücel
Journal:  Turk J Urol       Date:  2013-12

6.  Evaluation and treatment of pediatric idiopathic urolithiasis-revisited.

Authors:  Uri S Alon; Hannah Zimmerman; Michal Alon
Journal:  Pediatr Nephrol       Date:  2004-03-11       Impact factor: 3.714

Review 7.  Medical treatment of pediatric urolithiasis.

Authors:  Uri S Alon
Journal:  Pediatr Nephrol       Date:  2008-02-14       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.